Insider Selling: Safeguard Scientifics Director Unloads 4,166 Shares of Stock (SFE)
Safeguard Scientifics (NYSE:SFE) Director Julie Dobson sold 4,166 shares of Safeguard Scientifics stock in a transaction that occurred on Wednesday, September 11th. The stock was sold at an average price of $14.74, for a total value of $61,406.84. Following the completion of the transaction, the director now directly owns 12,166 shares in the company. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Several analysts have recently commented on the stock. Analysts at Zacks upgraded shares of Safeguard Scientifics (NYSE:SFE) from an “underperform” rating to a “neutral” rating in a research note to investors on Tuesday, August 27th. They now have a $15.10 price target on the stock. Separately, analysts at Janney Montgomery Scott initiated coverage on shares of Safeguard Scientifics (NYSE:SFE) in a research note to investors on Thursday, August 15th. They set a “neutral” rating on the stock.
Two analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $18.87.
Shares of Safeguard Scientifics (NYSE:SFE) traded down 0.87% on Wednesday, hitting $14.87. The stock had a trading volume of 20,338 shares. Safeguard Scientifics has a 52-week low of $13.15 and a 52-week high of $18.00. The stock has a 50-day moving average of $14.97 and a 200-day moving average of $15.69. The company’s market cap is $401.1 million.
Safeguard Scientifics (NYSE:SFE) last announced its earnings results on Thursday, July 25th. The company reported ($1.33) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.43) by $0.90. During the same quarter last year, the company posted ($0.48) earnings per share. On average, analysts predict that Safeguard Scientifics will post $-1.26 earnings per share for the current fiscal year.
Safeguard Scientifics, Inc provides growth capital for entrepreneurial and innovative life sciences and technology companies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.